Addressing Sexual Dysfunction After Risk-Reducing Salpingo-Oophorectomy: Effects of a Brief, Psychosexual Intervention

Journal of Sexual Medicine

Volumn 12, Issue 1, 2015, Pages 189-197

  Bober, Sharon L ^a,b   Recklitis, Christopher J ^a,b   Bakan, Jennifer ^a   Garber, Judy E ^a,b   Patenaude, Andrea F ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Quality of Life and Cancer; Risk Reducing Salpingo Oophorectomy and Sexual Dysfunction; Sexual Health and Cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

ADULT; ANXIETY DISORDER; AROUSAL; ARTICLE; AWARENESS; BREAST CANCER; BRIEF SYMPTOM INVENTORY; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; FEMALE SEXUAL DYSFUNCTION; FEMALE SEXUAL FUNCTION INDEX; GENE MUTATION; GENITAL SYSTEM DISEASE ASSESSMENT; GLOBAL SEVERITY INDEX; HEALTH EDUCATION; HUMAN; KNOWLEDGE; MINDFULNESS; ORGASM; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOSEXUAL DEVELOPMENT; RELAXATION TRAINING; RISK REDUCTION; SALPINGOOOPHORECTOMY; SELF CONCEPT; SEXUAL EDUCATION; SEXUAL FUNCTION; SEXUAL KNOWLEDGE SCALE; SEXUAL SATISFACTION; SEXUAL SELF EFFICACY SCALE; SEXUALITY; SOMATIZATION; VAGINAL LUBRICATION; DIRECTIVE COUNSELING; EVALUATION STUDY; FEASIBILITY STUDY; GENETIC PREDISPOSITION; GENETICS; MUTATION; OVARIAN NEOPLASMS; OVARIECTOMY; PILOT STUDY; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; SALPINGECTOMY; SATISFACTION; SEXUAL BEHAVIOR;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; COGNITIVE THERAPY; DIRECTIVE COUNSELING; FEASIBILITY STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; OVARIAN NEOPLASMS; OVARIECTOMY; PERSONAL SATISFACTION; PILOT PROJECTS; QUALITY OF LIFE; RISK REDUCTION BEHAVIOR; SALPINGECTOMY; SELF EFFICACY; SEXUAL BEHAVIOR;

EID: 84923223801     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12713     Document Type: Article

References (39)

1. American Cancer Society. Cancer facts & figures 2013. Atlanta, GA: American Cancer Society; 2013.
2. National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian cancer (v 1.2014). National Comprehensive Cancer Network, 2014.
3. Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, Neuhausen SL, Daly MB, Matloff E, Blum JL, Sabbatini P, Barakat RR, Hudis C, Norton L, Offit K, Rebbeck TR. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: A multicenter, prospective study. J Clin Oncol 2008;26:1331-1337. doi: 10.1200/JCO.2007.13.9626.
4. Robson M, Hensley M, Barakat R, Brown C, Chi D, Poynor E, Offit K. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol Oncol 2003;89:281-287. doi: S0090825803000726. [pii].
5. Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol 2009;112:594-600. doi: 10.1016/j.ygyno.2008.11.039.
6. Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, Esplen MJ, Demsky R, Murphy J, Rosen B, Narod SA. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol 2011;121:163-168. doi: 10.1016/j.ygyno.2010.12.326.
7. Vanchieri C. Risk reduction works for BRCA mutation carriers-with heavy costs. J Natl Cancer Inst 2005;97:1032-1033. doi: 10.1093/jnci/dji228.
8. Campfield Bonadies D, Moyer A, Matloff ET. What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy. Fam Cancer 2011;10:79-85. doi: 10.1007/s10689-010-9384-z.
9. Matloff ET, Barnett RE, Bober SL. Unraveling the next chapter: Sexual development, body image, and sexual functioning in female BRCA carriers. Cancer J 2009;15:15-18. doi: 10.1097/PPO.0b013e31819585f1.
10. Hallowell N, Baylock B, Heiniger L, Butow PN, Patel D, Meiser B, Saunders C, kConFab Psychosocial Group on behalf of the KConFab investigators, Price MA. Looking different, feeling different: Women's reactions to risk-reducing breast and ovarian surgery. Fam Cancer 2012;11:215-224. doi: 10.1007/s10689-011-9504-4.
11. Davis CS, Zinkand JE, Fitch MI. Cancer treatment-induced menopause: Meaning for breast and gynecological cancer survivors. Can Oncol Nurs J 2000;10:14-21.
12. Abbott-Anderson K, Kwekkeboom KL. A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol 2012;124:477-489. doi: 10.1016/j.ygyno.2011.11.030.
13. Finch A, Narod SA. Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review. Maturitas 2011;70:261-265. doi: 10.1016/j.maturitas.2011.08.001.
14. Brotto LA, Erskine Y, Carey M, Ehlen T, Finlayson S, Heywood M, Kwon J, McAlpine J, Stuart T, Thompson S, Miller D. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer. Gynecol Oncol 2012;125:320-325. doi: 10.1016/j.ygyno.2012.01.035.
15. Canada AL, Schover LR, Li Y. A pilot intervention to enhance psychosexual development in adolescents and young adults with cancer. Pediatr Blood Cancer 2007;49:824-828. doi: 10.1002/pbc.21130.
16. Schover LR, Yuan Y, Fellman BM, Odensky E, Lewis PE, Martinetti P. Efficacy trial of an internet-based intervention for cancer-related female sexual dysfunction. J Natl Compr Canc Netw 2013;11:1389-1397.
17. Bober SL, Varela VS. Sexuality in adult cancer survivors: Challenges and intervention. J Clin Oncol 2012;30:3712-3719. doi: 10.1200/JCO.2012.41.7915.
18. Bober SL, Carter J, Falk S. Addressing female sexual function after cancer by internists and primary care providers. J Sex Med 2013;10(1 suppl):112-119. doi: 10.1111/jsm.12027.
19. Hofmann SG, Sawyer AT, Fang A. The empirical status of the "new wave" of cognitive behavioral therapy. Psychiatr Clin North Am 2010;33:701-710. doi: 10.1016/j.psc.2010.04.006.
20. Scott JL, Kayser K. A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer. Cancer J 2009;15:48-56. doi: 10.1097/PPO.0b013e31819585df.
21. Caldwell R, Classen C, McGarvey E, Lagana L, Baum L, Duenke SD, Koopman C. Changes in sexual functioning and mood among women treated for gynecological cancer who receive group therapy: A pilot study. J Clin Psychol Med Settings 2003;10:149-156.
22. Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: A meta-analysis of randomized experiments. Health Psychol 1995;14:101-108.
23. Syrjala KL, Schroeder TC, Abrams JR, Atkins TZ, Brown WS, Sanders JE, Schubert MA, Heiman JR. Sexual function measurement and outcomes in cancer survivors and matched controls. J Sex Res 2000;37:213-225. doi: 10.1080/00224490009552042.
24. Kabat-Zinn J. Full catastrophe living: using the wisdom of your mind and body to face stress, pain, and illness. New York, NY: Delta Trade Paperbacks; 1990.
25. Heiman JR, LoPiccolo J. Becoming orgasmic: a sexual and personal growth program for women. New York, NY: Prentice Hall; 1998.
26. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208. doi: 10.1080/009262300278597.
27. Baser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer 2012;118:4606-4618. doi: 10.1002/cncr.26739.
28. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1-20. doi: 10.1080/00926230590475206.
29. Derogatis LR. BSI 18, Brief Symptom Inventory 18: Administration, Scoring and Procedure Manual. Minneapolis, MN: NCS Pearson, Incorporated; 2001.
30. Desrochers G, Bergeron S, Khalife S, Dupuis MJ, Jodoin M. Provoked vestibulodynia: Psychological predictors of topical and cognitive-behavioral treatment outcome. Behav Res Ther 2010;48:106-115. doi: 10.1016/j.brat.2009.09.014.
31. Robinson JW, Faris PD, Scott CB. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 1999;44:497-506.
32. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
33. Fruhauf S, Gerger H, Schmidt HM, Munder T, Barth J. Efficacy of psychological interventions for sexual dysfunction: A systematic review and meta-analysis. Arch Sex Behav 2013;42:915-933. doi: 10.1007/s10508-012-0062-0.
34. Schover LR, Jenkins R, Sui D, Adams JH, Marion MS, Jackson KE. Randomized trial of peer counseling on reproductive health in African American breast cancer survivors. J Clin Oncol 2006;24:1620-1626. doi: 10.1200/JCO.2005.04.7159.
35. Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric-Bernstam F, Gonzalez-Angulo AM, Bodurka DC, Lu KH, Hortobagyi GN, Arun BK. Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer 2009;115:1598-1604. doi: 10.1002/cncr.24199.
36. Reese JB, Porter LS, Somers TJ, Keefe FJ. Pilot feasibility study of a telephone-based couples intervention for physical intimacy and sexual concerns in colorectal cancer. J Sex Marital Ther 2012;38:402-417. doi: 10.1080/0092623X.2011.606886.
37. Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: Model, processes and outcomes. Behav Res Ther 2006;44:1-25. doi: 10.1016/j.brat.2005.06.006.
38. Segal ZV, Williams JG, Teasdale JD. Mindfulness-based cognitive therapy for depression. 2nd edition. New York, NY: Guilford Press; 2012.
39. Stead ML, Brown JM, Fallowfield L, Selby P. Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer 2003;88:666-671. doi: 10.1038/sj.bjc.6600799.